Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-024991
Filing Date
2018-04-16
Accepted
2018-04-16 16:24:58
Documents
1
Period of Report
2018-04-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9135
  Complete submission text file 0001209191-18-024991.txt   10676
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O WYRICK ROBBINS YATES & PONTON LLP 4101 LAKE BOONE TRAIL, SUITE 300 RALEIGH NC 27607
Business Address
Reynolds Donald Rogers (Reporting) CIK: 0001687930 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 18756872